AZNVSBIAF• 3 Months (Normalized)
AZN vs BIAF (AstraZeneca PLC vs bioAffinity Technologies Inc.)
Showing Closing Date Range from Jun, 16 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AZN Performance $164.01
-8.23%
AstraZeneca PLC
Normalized Baseline0.00%
BIAF Performance $7.91
-44.2%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
Alpha Spread Margin AZN LEADS
+35.97%
AZN outperforming by 35.97%
AZNBIAF
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AZN BIAF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | AZN Price | AZN Gain (%) | BIAF Price | BIAF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $164.01 | -8.23% | $7.91 | -44.20% | +35.97% |
| Sep 11, 2026 | $160.17 | -10.37% | $7.95 | -43.92% | +33.55% |
| Sep 10, 2026 | $159.64 | -10.67% | $9.39 | -33.76% | +23.09% |
| Sep 09, 2026 | $156.94 | -12.18% | $10.50 | -25.93% | +13.75% |
| Sep 08, 2026 | $160.04 | -10.45% | $8.93 | -37.00% | +26.55% |
| Sep 04, 2026 | $162.70 | -8.96% | $15.27 | +7.72% | -16.68% |
| Sep 03, 2026 | $164.77 | -7.80% | $12.78 | -9.84% | +2.04% |
| Sep 02, 2026 | $161.63 | -9.56% | $9.75 | -31.22% | +21.66% |
| Sep 01, 2026 | $162.47 | -9.09% | $6.59 | -53.51% | +44.42% |
| Aug 31, 2026 | $162.13 | -9.28% | $4.56 | -67.83% | +58.55% |
| Aug 28, 2026 | $162.70 | -8.96% | $4.87 | -65.64% | +56.68% |
| Aug 27, 2026 | $164.52 | -7.94% | $5.06 | -64.30% | +56.36% |
| Aug 26, 2026 | $166.27 | -6.96% | $5.09 | -64.09% | +57.13% |
| Aug 25, 2026 | $169.66 | -5.06% | $5.19 | -63.39% | +58.33% |
| Aug 24, 2026 | $166.71 | -6.71% | $5.82 | -58.94% | +52.23% |
Page 1 of 5